TY  - JOUR

T1  - The role of RANK/RANKL/osteoprotegerin (OPG) triad in cancer-induced bone diseases: physiopathology and clinical implications

JO  - Bulletin du Cancer

PY  - 2011/07/01

AU  - Clézardin P

ED  - 

DO  - DOI: 10.1684/bdc.2011.1398

PB  - Elsevier BV

VL  - 98

IS  - 7

SP  - 837

EP  - 846

Y2  - 2025/10/26

ER  -